Acadia Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 9.12, indicating more challenging environment then in the fourth quarter 2025, but still, it is a far cry from any concerns. Acadia Pharmaceuticals Inc 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 40 days, from 38 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 172 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 0 to 1328.

What is Receivable Turnover Ratio?
What is Acadia Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ACAD Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	28 %	23.01 %	17.96 %	3.67 %	11.66 %
Y / Y Revenue Change	9.72 %	9.39 %	11.27 %	9.34 %	18.7 %
Receivable Turnover Ratio (TTM)	9.12	9.51	9.79	9.94	9.81
ACAD's Total Ranking	# 1328	# 0	# 431	# 911	# 1218
Accounts Receivable average collection period days	40	38	37	37	37
Seq. Receivable Change	11.44 %	4.84 %	7.76 %	1.67 %	7.09 %
Seq. Revenue Change	-5.61 %	1.92 %	5.32 %	8.29 %	-5.89 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 41
Healthcare Sector	# 173
Overall Market	# 1328

Receivable Turnover Ratio Statistics
High	Average	Low
1.27	0.57	0
(Dec 31 2018)		(Mar 31 2016)

ACAD Company Profile • Back to ACAD Efficiency Comparisons • Compare ACAD Receivables Turnover Ratio to its Competitors

Financial Statements
Acadia Pharmaceuticals Inc 's Accounts Receivable	$ 135 Millions	Visit ACAD's Balance sheet
Acadia Pharmaceuticals Inc 's Sales TTM	$ 1,095 Millions	Visit ACAD's Income Statement
Sources of ACAD's Revenues		Visit ACAD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ACAD's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ACAD's Growth Rates	ACAD's Roa	ACAD's Inventory Turnover Ratio	ACAD's Dividend Comparisons
ACAD's Profitability Ratios	ACAD's Roi	ACAD's Asset Turnover Ratio	ACAD's Dividend Growth
ACAD's Valuation Ratios	ACAD's Roe	ACAD's Financial Strength Ratios	ACAD's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Lipocine Inc	22.09	$ 2.002 Millions	$ 0.091 Millions
Ataibeckley Inc	21.56	$ 3.488 Millions	$ 0.162 Millions
Fonar Corporation	21.15	$ 105.338 Millions	$ 4.981 Millions
Neuraxis Inc	20.94	$ 4.282 Millions	$ 0.204 Millions
Vystar Corporation	20.58	$ 0.048 Millions	$ 0.002 Millions
Lifemd Inc	19.91	$ 177.869 Millions	$ 8.934 Millions
Longeveron Inc	19.07	$ 1.216 Millions	$ 0.064 Millions
Sonida Senior Living Inc	18.82	$ 411.850 Millions	$ 21.878 Millions
Voyager Therapeutics Inc	17.99	$ 36.494 Millions	$ 2.029 Millions
Nutriband Inc	16.79	$ 1.803 Millions	$ 0.107 Millions
Bioadaptives Inc	16.64	$ 0.024 Millions	$ 0.001 Millions
Premier Air Charter Holdings Inc	16.33	$ 33.205 Millions	$ 2.033 Millions
Bioage Labs Inc	15.90	$ 10.316 Millions	$ 0.649 Millions
Escalon Medical Corp	15.15	$ 11.445 Millions	$ 0.756 Millions
Nurix Therapeutics Inc	15.11	$ 71.779 Millions	$ 4.750 Millions
Lexicon Pharmaceuticals Inc	14.91	$ 69.643 Millions	$ 4.670 Millions
Qhslab Inc	14.80	$ 2.775 Millions	$ 0.188 Millions
Nexgel Inc	14.19	$ 10.382 Millions	$ 0.732 Millions
Sutro Biopharma Inc	14.04	$ 99.608 Millions	$ 7.095 Millions
Precipio inc	13.93	$ 25.831 Millions	$ 1.854 Millions
China Pharma Holdings Inc	13.86	$ 3.992 Millions	$ 0.288 Millions
Talkspace Inc	13.67	$ 239.269 Millions	$ 17.501 Millions
Marpai Inc	13.59	$ 17.125 Millions	$ 1.261 Millions
Amneal Pharmaceuticals Inc	13.56	$ 3,045.530 Millions	$ 224.634 Millions
Corcept Therapeutics Inc	13.20	$ 769.096 Millions	$ 58.264 Millions
Rosecliff Acquisition Corp I	13.19	$ 20.547 Millions	$ 1.557 Millions
Xoma Royalty Corporation	13.05	$ 48.555 Millions	$ 3.720 Millions
Mannkind Corporation	13.00	$ 360.783 Millions	$ 27.757 Millions
Lifestance Health Group Inc	12.74	$ 1,494.791 Millions	$ 117.296 Millions
Chemed Corporation	12.73	$ 2,540.548 Millions	$ 199.626 Millions

Date modified: 2026-09-08T15:31:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.